Leigh Shultz, Phd, Mba Email & Phone Number

Rahway, New Jersey, Us

* Lead a commercial center of excellence in the Human Health International business focused on supporting ex-US markets to evolve and optimize commercial strategies and product distribution to enable patient access and optimize margins* Partner with Commercial, Market Access, and Finance colleagues to identify and execute on short-run opportunities to drive net sales through channel and account management strategies* Work with global, regional, and local colleagues to optimize route to customer strategies, both at launch and over the product lifecycle* Sponsor implementation of digital capabilities across distribution channels to modernize operations, improve customer experience, and drive growth* Build and support commercial contracting and alliance management capabilities across ex-US markets* Lead Generative AI activities across the international business

Rahway, New Jersey, Us

* Co-led the reconfiguration of gross-to-net accounting standards across >50 ex-US markets to create consistency, drive proactive identification of opportunities to improve margins, and enable real-time data and analytics* Articulated the business case for e-commerce globally and led the initial implementation of the capability across markets to drive top- and bottom-line growth through a connected, digital customer experience and data-driven customer insights* Sponsored the implementation and scaling of statistical demand forecasting across the commercial portfolio* Received consistently strong feedback from stakeholders in teams, functions, and markets for customer-centric ways of working, inclusive behaviors, enterprise thinking, and financial acumen

Rahway, New Jersey, Us

* Head, Non-Oncology R&D Project Management. Accountable for projects and PM staff across vaccines, infectious disease, general medicine, and all Discovery therapeutic areas (~50 staff); dotted-line accountability for China and Japan R&D PM teams. Previous accountabilities include leadership of the R&D Alliance Management function and leadership of the Global Project & Alliance Management (GPAM) PMO.* Meeting Manager for the Human Health Portfolio Approval Committee (HHPAC), the enterprise governance committee accountable for asset investment decisions across the US$10B R&D portfolio, including oncology. * R&D Divisional Lead, COVID-19 Senior Executive Crisis Team. Sole representative for R&D on the operations team ensuring enterprise business continuity during the COVID-19 pandemic.* Sponsor, R&D Risk Management and Business Continuity. Drove creation of the R&D Risk Management Process, including identification and management of risks and associated mitigation plans; work resulted in reallocation of the corporate IT budget to address key risks in R&D. * Leader of an enterprise initiative to reimagine the global process for creating, approving, maintaining, and retiring promotional content across the commercial portfolio. Collaborated with global stakeholders to redesign this core business process, demonstrating >20% efficiency post-implementation.* Lead for creation and maintenance of the R&D Divisional Scorecard and Operational Reviews. Developed a quantitative process for status updates to inform R&D leadership and corporate compensation planning. Accountable for quarterly refreshes of the internal development pipeline view and associated pipeline reporting to the Executive Committee.* Leader/member of multiple divisional and cross-divisional initiatives to develop and improve key business and people processes, including an effort to clarify Merck’s approach to pre-license access and integrated commercialization strategies.

Rahway, New Jersey, Us

* Therapeutic Area (TA) Head, Diabetes & Endocrinology Project Management. Accountable for delivery of projects and development of staff across Diabetes & Endocrinology projects (~15 staff); reported directly to the SVP, GPAM.* Member, PM Senior Leadership Team. Managed up to 8 directors with responsibility for ~40 PMs and delivery of projects across all therapeutic areas. Collaborated to design an empirical algorithm to inform PM resourcing based on project complexity.* Project Manager, R&D Restructuring Team. Worked directly with R&D leadership to develop and executing plans for corporate restructuring. * Project Leader, Product Development. Project Leader for a Phase 3 Product Development Team in osteoporosis; led team through unblinding of the Phase 3 outcomes trial, pre-NDA meeting with FDA, and public presentation of Phase 3 data.

Rahway, New Jersey, Us

* Project Management TA Lead, Bone/Respiratory/Immunology/Endocrine Franchise, including products such as JANUVIA, SINGULAIR, and FOSAMAX.* People Manager. Managed a group of ~4 project managers on bone and urology projects and was accountable for projects in these therapeutic areas. * Project Manager, bone and respiratory products, including SINGULAIR and a Phase 3 Product Development Team in osteoporosis.* Senior Research Chemist, Pre-formulation/Basic Research Support, Pharmaceutical R&D. Led the characterization/selection of the phosphate salt of sitagliptin ultimately commercialized in JANUVIA.

Executive Mba, Strategy And Finance

Phd, Inorganic Chemistry

Executive Education Program, Enterprise Leadership

Executive Education Program, Management Accelerations

Executive Education Program, Business Leadership Program

Bs, Chemistry With Highest Honors

Education record

Education record